R.PR
REGISTERED-PRINCIPAL REGISTER
01/11/2022
Back to search
Official data from USPTO
CRPHAGE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
01/11/2022
Trademark type
Word
Nice classes
42
Filing date
10/26/2018
Registration date
01/11/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/11/2022
Last transaction
01/11/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/02/2019
First use in commerce
01/02/2019
Drawing code
4
Owner type
03
Owner location
Morrisville, NC, US
Examiner
PATEL, SAMIR
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Locus Biosciences, Inc.
Locus Biosciences, Inc.
Representatives
Chelsea E. Carbone WILSON SONSINI GOODRICH & ROSATI
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical research and development; research and development in pharmacology for the purpose of targeting and destroying bacteria; medical research for use in treating antibiotic-resistant bacterial infections and microbiome-related disorders; medical and scientific research; pharmaceutical research in the field of engineered bacteriophage; pharmaceutical research using engineered therapeutics for use in antibacterial drug development; pharmaceutical researchresearch relating to engineered bacteriophage platforms for improving pharmacological properties; pharmaceutical researchresearch relating to engineered bacteriophages for use in connection with a wide variety of therapeutic agents
Publications
History of USPTO decisions and trademark events.
35 publications found
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/08/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/07/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/20/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/19/2021
EX5G
SOU EXTENSION 5 GRANTED
11/19/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/19/2021
IUAF
USE AMENDMENT FILED
11/12/2021
EXT5
SOU EXTENSION 5 FILED
11/12/2021
EEXT
SOU TEAS EXTENSION RECEIVED
11/12/2021
EISU
TEAS STATEMENT OF USE RECEIVED
11/12/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/12/2021
EX4G
SOU EXTENSION 4 GRANTED
05/10/2021
EXT4
SOU EXTENSION 4 FILED
05/10/2021
EEXT
SOU TEAS EXTENSION RECEIVED
05/10/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/29/2020
EX3G
SOU EXTENSION 3 GRANTED
10/27/2020
EXT3
SOU EXTENSION 3 FILED
10/27/2020
EEXT
SOU TEAS EXTENSION RECEIVED
10/27/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/14/2020
EX2G
SOU EXTENSION 2 GRANTED
05/12/2020
EXT2
SOU EXTENSION 2 FILED
05/12/2020
EEXT
SOU TEAS EXTENSION RECEIVED
05/12/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/28/2019
EX1G
SOU EXTENSION 1 GRANTED
08/26/2019
EXT1
SOU EXTENSION 1 FILED
08/26/2019
EEXT
SOU TEAS EXTENSION RECEIVED
08/26/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/14/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/19/2019
PUBO
PUBLISHED FOR OPPOSITION
03/19/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/27/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/04/2019
DOCK
ASSIGNED TO EXAMINER
02/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/10/2018
NWAP
NEW APPLICATION ENTERED
10/30/2018
Continuous trademark protection
Get notified about every new filing that threatens CRPHAGE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.